Fucosyltransferase 1 and 2 play pivotal roles in breast cancer cells. by Lai, Tai-Yu et al.
UC San Diego
UC San Diego Previously Published Works
Title


















eScholarship.org Powered by the California Digital Library
University of California
Lai et al. Cell Death Discovery            (2019) 5:74 
https://doi.org/10.1038/s41420-019-0145-y Cell Death Discovery 
ART ICLE Open Ac ce s s
Fucosyltransferase 1 and 2 play pivotal
roles in breast cancer cells
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Abstract
FUT1 and FUT2 encode alpha 1, 2-fucosyltransferases which catalyze the addition of alpha 1, 2-linked fucose to
glycans. Glycan products of FUT1 and FUT2, such as Globo H and Lewis Y, are highly expressed on malignant tissues,
including breast cancer. Herein, we investigated the roles of FUT1 and FUT2 in breast cancer. Silencing of FUT1 or FUT2
by shRNAs inhibited cell proliferation in vitro and tumorigenicity in mice. This was associated with diminished
properties of cancer stem cell (CSC), including mammosphere formation and CSC marker both in vitro and in
xenografts. Silencing of FUT2, but not FUT1, significantly changed the cuboidal morphology to dense clusters of small
and round cells with reduced adhesion to polystyrene and extracellular matrix, including laminin, fibronectin and
collagen. Silencing of FUT1 or FUT2 suppressed cell migration in wound healing assay, whereas FUT1 and FUT2
overexpression increased cell migration and invasion in vitro and metastasis of breast cancer in vivo. A decrease in
mesenchymal like markers such as fibronectin, vimentin, and twist, along with increased epithelial like marker, E-
cadherin, was observed upon FUT1/2 knockdown, while the opposite was noted by overexpression of FUT1 or FUT2.
As expected, FUT1 or FUT2 knockdown reduced Globo H, whereas FUT1 or FUT2 overexpression showed contrary
effects. Exogenous addition of Globo H-ceramide reversed the suppression of cell migration by FUT1 knockdown but
not the inhibition of cell adhesion by FUT2 silencing, suggesting that at least part of the effects of FUT1/2 knockdown
were mediated by Globo H. Our results imply that FUT1 and FUT2 play important roles in regulating growth, adhesion,
migration and CSC properties of breast cancer, and may serve as therapeutic targets for breast cancer.
Introduction
Glycoconjugates have long been recognized as essential
components of many living organisms. A number of
studies have documented the roles of glycoconjugates in a
variety of diseases such as viral and bacterial infection,
inflammation, autoimmune dysfunction, or cancer
metastasis1. However, our knowledge on how glyco-
conjugates are involved in these processes remains lim-
ited. Recently, specific glycan structures have been
reported to correlate with breast tumor progression, such
as sialyl-Tn (sTn), Lewisy (Ley), sialyl-Lewisa (sLea), sialyl-
Lewisx (sLex), sLex-Lex, Thomas Friedrich (TF), Globo H,
polysialic acid (PSA) and GM22–5.
Among these tumor associated glycans, the terminal
alpha 1, 2-linked fucose of Lewisy and Globo H are syn-
thesized by alpha 1, 2 fucosyltransferase, FUT1 and FUT2,
in human6,7. These alpha 1, 2 fucosyltransferases are
Golgi stack membrane enzymes that catalyze the transfer
of alpha 1, 2-linked fucose to the galactose residue of
glycans. In addition to breast cancer, altered cell surface
alpha 1, 2-fucosylated glycans have been found in a variety
of malignancies such as cancers of colon, pancreas,
endometrium, cervix, bladder, lung and choriocarcinoma.
FUT1 and FUT2 null mice develop normally and exhibit
no gross phenotypic abnormalities, despite absence of
Fucα2Galβ epitope in the epididymal epithelium and
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uterine epithelium, respectively8. It has also been shown
that FUT1 and FUT2 selectively substitutes galactose
residue on glycoconjugates in tissue-specific manner. For
example, fucosyl GA1 (FGA1) is lost from pancreas in
FUT1-null mice, whereas, both FGA1 and fucosyl GM1
(FGM1) are completely absent in antrum, cecum, and
colon in FUT2-null mice9. In addition, FUT1 and FUT2
are capable of generating FGM1 and Globo H in small cell
lung cancer cells and breast cancer cells, respectively10,11.
A numbers of recent studies have implicated important
functions of FUT1 and FUT2 in colon cancers. For
instance, FUT1 overexpression in HT-29/M3 colon can-
cer cells induces synthesis of H type 2 and Ley and
decrease in sLex, which results in altered glycosylation
patterns of MUC1 and MUC5AC apomucins with
reduced interaction with E-selectin, leading to greater
invasive and metastatic capacities12–14. Indeed, over-
expression of FUT1 in rat colon carcinoma results in
increased tumorigenicity, increased resistance to apopto-
sis and facilitated escape from immune surveillance15,16.
In addition to colon cancer, FUT1 transgenic studies
show enhanced vasculogenesis and gastrointestinal
metastatic ability of pancreatic cancer cells (BxPC3), but
greatly retarded the growth of hepatic cancer cells
(HepG2) due to dramatic decrease in sLex expression,
increase in Ley and Leb expression with failure to interact
with endothelial E-selectin14,17,18. Suppression of FUT1
and FUT4 by siRNA reduces Ley expression and inhibits
cell proliferation through decreased EGFR signaling
pathway in epidermoid carcinoma cells (A431)19. Recent
studies have shown that alpha 1, 2 fucosyltransferase
induces angiogenesis by activating ERK1/2, promotes
metastasis by increasing MMP-2 and MMP-9, and
accelerates hepatocellular carcinoma progression by
influencing Notch signaling and multidrug resistance by
inducing PI3K/Akt signaling pathway20–23.
In breast cancer, GSL profiling by mass spectrometry
showed that FUT1 contributed to the biosynthesis of
Globo H and fucosyl-lactoceramide24 with our previous
report that both FUT1 and FUT2 contribute to the
expression of Globo H in breast cancers10. We also
demonstrated that FUT1 regulated fucosylation of
LAMP-1 and LAMP-2 to modulate autophagic flux rate
via mTOR signaling and autolysosome formation25. An
in vitro study showed that FUT1 knockdown reduces cell
proliferation of a HER2-overexpressing gastric cancer
cells (NCI-N87)26. However, the roles of FUT1 and FUT2
in cancer stem cells (CSCs) and tumorigenicity of breast
cancer have yet to be delineated.
Here, we investigated the impacts of alpha 1, 2-linked
fucose on breast cancer biology and CSC properties using
lentiviral system to knockdown and electroporation to
overexpress FUT1 and FUT2.. We showed that FUT1
and FUT2 played pivotal roles in the regulation of CSC
properties, including cell proliferation, epithelial-
mesenchymal transition, tumorigenesis, and metastasis.
Results
Silencing of FUT1 and FUT2 inhibits cell proliferation
in vitro and tumorigenicity in vivo
To investigate whether inhibition of FUT1 or FUT2 has
functional consequences in breast cancer, lentiviral-based
short hairpin RNA (shRNA) was employed to establish
stable cell lines with silenced expression of FUT1
(shFUT1) or FUT2 (shFUT2) in T47D cells, which
expressed significantly more FUT2 than FUT1, and MCF7
cells, which expressed high FUT1 but negligible FUT2. As
shown in Fig. 1a, transfection of T47D cells with two
lentiviral constructs of shFUT1 (shFUT1 #a and shFUT1
#b) suppressed FUT1 expression to 24% and 38% of
control shLuc, respectively, and transfection with three
lentiviral constructs of shFUT2 (shFUT2 #a, shFUT2 #b,
and shFUT2 #c) reduced FUT2 expression to 59%, 58%,
and 35% of control shLuc. Similarly, FUT1 expression in
MCF-7 cells was suppressed to 38% and 43% of control by
shFUT1#a and shFUT1#b, respectively (Fig. 1b). As
shown in Fig. 1c, d, the cell proliferation rates were
reduced by FUT2- and FUT1-silencing in T47D to 60% of
control cells expressing shLuc, and by shFUT1#a and #b
in MCF7 cells to 20% and 28%, respectively. To further
examine if this in vitro phenotype could be recapitulated
in vivo, FUT1 or FUT2-silenced T47D and MCF7 cells
were inoculated into the mammary fat pad of NOD/SCID
mice. Tumor growth rates in T47D and MCF7 xenografts
were significantly decreased by 65% and 70%, respectively,
upon FUT1 knockdown (Fig. 1e, f). FUT2-silencing in
T47D dramatically reduced tumor volume by 95%
(Fig. 1e). In short, both FUT1 and FUT2 are important for
tumor growth in vitro and in vivo.
Silencing of FUT1 and FUT2 reduces mammosphere
formation and CSC-like subpopulation
Accumulating evidence suggests that breast cancer is
initiated and maintained by a small subpopulation of
cancer stem cells that possess the capacity for self-renewal
which drives tumorigenesis and aberrant differentiation
that provides cellular heterogeneity27,28. Such breast
cancer stem cells display the ability to form mammo-
spheres in vitro29. FUT1 knockdown significantly reduced
the capacity of mammosphere forming capacity of T47D
and MCF7 cells to 40% of control cells expressing shLuc
(Fig. 2a, b). The FUT2 silenced T47D only formed 35%
mammosphere of control cells (Fig. 2a). In cells harvested
from xenografted tumor of T47D and MCF7, silencing of
FUT2 or FUT1 similarly reduced mammosphere forma-
tion by 75% and 65%, respectively, as compared to that in
shLuc control (Fig. 2c, d). In addition, knockdown of
FUT2 in T47D and FUT1 in MCF7 cells reduced the
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CSC-enriched subpopulation (CD44+/CD24−) from 0.2%
to 0.1% and from 3.3% to 1.8%, respectively (Fig. 2e, f).
The CD44+/CD24+ subpopulation also decreased from
24.8% to 14.9% in T47D and from 14.6% to 4.3% in MCF7
(Fig. 2e, f). According to the mainstream literature,
CD44+/CD24− has been designated as CSC marker of
breast cancer, including T47D and MCF-7;30,31 however, a
few other studies suggested CD44+/CD24+ subpopula-
tion also display CSC-like properties32. These findings
demonstrate that both FUT1 and FUT2 play important
roles in the functional properties of breast cancer stem
cells.
Silencing of FUT2 reduces cell adhesion and cell-matrix
interaction
FUT2 knockdown changed the morphology of T47D
from large cuboidal cells to dense clusters of small and
round cells with increased number of detached floating
cells (Fig. 3a), accounting for 42% of the cells (Fig. 3b),
while silencing FUT1 in T47D had no significant effect on
the cell morphology although the growth rate was retar-
ded (Fig. 3a and 1c). MCF7 with shLuc control grew as
monolayer of polygonal cells which were well spread out
on culture dishes, whereas FUT1 knockdown displayed an
unusual growth pattern with clusters of 15–30 small,
round to oval cells surrounded by sharply demarcated
borders (Fig. 3a). To determine whether cell-matrix
interaction was affected by FUT1 and FUT2, cell adhe-
sion assay was performed in 96-well microtiter plates
coated with laminin, fibronectin, or collagen IV. FUT2
knockdown in T47D cells significantly decreased cell-
matrix interactions, whereas FUT2 overexpression (Sup-
plementary Figure 1a) increased cell adhesion to all 3
matrix proteins (Fig. 3c). In contrast, FUT1 knockdown
had no effects on cell-matrix interaction except for a
slightly reduced adhesion to collagen IV, while FUT1
Fig. 1 Silencing FUT1 or FUT2 decreases cellular growth of breast cancer cells and suppresses xenograft tumor growth. a, T47D or b, MCF7
cells stably expressing shLuc, shFUT1, or shFUT2 were analyzed for FUT1 or FUT2 mRNA expression. Different shRNA clones were designated as #a, #b,
or #c. Cell proliferation of c, T47D or d, MCF7 cells expressing shLuc, shFUT1, or shFUT2 were determined by alamar blue assay. Tumor volume of e,
T47D and f, MCF7 were generated with data from 5 mice in each group. Values are mean ± SEM from three independent experiments. *p < 0.05;
**p < 0.01; ***p < 0.0001
Lai et al. Cell Death Discovery            (2019) 5:74 Page 3 of 12
Official journal of the Cell Death Differentiation Association
Fig. 2 Silencing FUT1 or FUT2 reduces mammosphere formation in T47D or MCF7 cells. a, T47D or b, MCF7 cells stably expressing shLuc,
shFUT1, or shFUT2 were analyzed for their mammosphere forming capability. c, d, T47D or MCF7 xenografted tumors with shLuc control, FUT1
knockdown, or FUT2 knockdown were harvested to determine their mammosphere forming capability. Values are mean ± SEM from three
independent experiments. Representative flow analysis of CSC subpopulation in e, T47D or f, MCF7 cells expressing shLuc, shFUT1, or shFUT2.
*p < 0.05; **p < 0.01; ***p < 0.0001
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overexpression enhanced the cell adhesion to laminin and
collagen IV (Fig. 3c). These results indicate that FUT2 is a
key regulatory of cell adhesion to extracellular matrix
components.
FUT1 and FUT2 regulate cell motility
To further investigate whether FUT1/FUT2 play a role
in cell migration, wound healing assay was performed.
FUT1 and FUT2 knockdown significantly diminished the
speed of wound closure to 20% and 15%, respectively, of
control cells both in T47D and MCF7 (Fig. 4a, b). In
addition, a highly-invasive breast cancer cell line, MDA-
MB-231, was used to investigate cell migration and
invasion toward serum. Both FUT1 and FUT2 over-
expression (Fig. 4c) markedly enhanced the transwell
migration rate by 3.33 fold and 2.22 fold, respectively, of
Fig. 3 Silencing FUT2 influences cell morphology and adhesion ability. a, A large portion of T47D cells expressing shFUT2, but not T47D or
MCF7 cells expressing shFUT1, detached from culture dish at 72 h after lentiviral infection. Scale bars, 200 μm. b, Adherent cells and floating cells
were collected and analyzed for cell number and viability by cell viability analyzer. c, The adhesion ability of T47D cells expressing shLuc, shFUT1, or
shFUT2 cultured on plate coated with laminin, fibronectin, or collagen were measured by RT-CES system up to 1 h. Values are mean ± SEM from three
independent experiments. *p < 0.05; **p < 0.01; ***p < 0.0001
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cells expressing vector control (Fig. 4d). In the matrigel
invasion assay, FUT1 and FUT2 overexpression also
increased cell invasion rate by 1.33 fold and 1.45 fold of
control, respectively (Fig. 4e). Furthermore, to determine
whether FUT1 and FUT2 promote breast cancer metas-
tasis in vivo, MDA-MB-231 stably and constitutively
expressing luciferase by lentiviral-mediated gene transfer
was transfected with empty vector, Flag-FUT1 or Flag-
FUT2. After tail vein injection of these cells into NOD/
SCID mice, FUT1 and FUT2 overexpression enhanced
tumor localization in the lungs by 2.56 fold and 5.3 fold,
respectively of vector control cells as determined by
luciferase luminescence (Supplementary Figures 2a and
b). This was consistent with greater tumor mass in lungs
as reflected by weight in mice injected with FUT1 and
FUT2 overexpressing cells than that in vector control cells
Fig. 4 FUT1 and FUT2 are involved in cell migration. Cell motility of a, T47D or b, MCF7 cells expressing shLuc, shFUT1, or shFUT2 was analyzed
by in vitro wound healing assay. The images were taken at 0 h and 48 h after the wounds were made. Scale bars, 500 μm. Bar graphs showed
percentage of remaining wound area over that of cells at 0 h, and normalized to shLuc control, which was set as 100%. c, MDA-MB-231 cells
expressing vector control, Flag-FUT1, or Flag-FUT2 were analyzed for FUT1 or FUT2 mRNA expression. d, Cell migration toward serum of MDA-MB-
231 cells with indicated conditions was determined by a RT-CIM system. e, Transwell assay for cell invasion of MDA-MB-231 cells with indicated
conditions. Values are mean ± SEM from three independent experiments. Scale bars, 50 μm. *p < 0.05; **p < 0.01; ***p < 0.0001
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(Supplementary Figures 2c and d). These results indicate
that FUT1 and FUT2 are important players in wound
healing, cell migration, and cell invasion.
FUT1 and FUT2 regulate epithelial-mesenchymal transition
(EMT)
In light of the impact of FUT1 and FUT2 on cancer
stem cells (CSC) and cell metastasis, we investigated the
role of FUT1 and FUT2 in epithelial-mesenchymal tran-
sition (EMT), which was considered a hallmark of CSC
and metastasis. The expression level of EMT markers was
determined by western blotting. As shown in Fig. 5, both
FUT1 and FUT2 knockdown enhanced levels of E-cad-
herin, while suppressing the levels of Twist, fibronectin
and vimentin in both T47D and MCF7 cells. In contrast,
FUT1 and FUT2 overexpression decreased levels of E-
cadherin and increased levels of fibronectin in MCF7, and
twist in T47D. These data support the involvement of
FUT1 and FUT2 in EMT process.
Contribution of Globo H-ceramide to FUT 1 and FUT2
regulated cell migration and adhesion
As FUT1 and FUT2 mediate the biosynthesis of glyco-
lipid Globo H-ceramide, we explore the possibility that
Globo H-ceramide may contribute in part to the observed
impacts of FUT1 and FUT2 on cell migration and adhe-
sion. As expected, FUT1 or FUT2 silenced T47D and
FUT1 silenced MCF7 tumors expressed decreased Globo
H by immunohistochemical staining and flow cytometry
with anti-Globo H antibody (Fig. 6a). Exogenous addition
of Globo H-ceramide increased cell surface expression of
Globo H to similar levels in T47D and MCF7 cells
transfected with shLuc, shFUT1, or shFUT2 (Fig. 6b).
Exogenous addition of Globo H-ceramide promoted cell
adhesion in T47D cells expressing shLuc, but could not
ameliorate the inhibitory effect of FUT2 knockdown on
cell adhesion (Fig. 6c). On the other hand, the addition of
Globo H-ceramide significantly increased transwell
migration of MCF7 and partially rescued the inhibition of
migration mediated by FUT1 knockdown (Fig. 6d). These
results suggest that cell migration and adhesion regulated
by FUT1 and FUT2 is in part contributed by Globo
H-ceramide, but also involves glycoproteins containing
alpha 1, 2-linked fucose.
Discussion
We have demonstrated the important roles of FUT1
and FUT2 in breast cancer as evidenced by their regula-
tion of cell morphology, proliferation, adhesion, migra-
tion, and mammosphere formation in vitro and
tumorigenicity and metastasis in vivo. Exogenous addition
of Globo H-ceramide, a glycan product of FUT1 and
FUT2, partially rescued shFUT1 reduced migration, but
not shFUT2 reduced cell adhesion.
Our findings are consistent with previous reports that
FUT1 increased alpha 1, 2-fucose of cell surface to pro-
mote tumorigenesis and metastasis in colon cancer12,13,
and that FUT1 served as a promoter for cancer progres-
sion in ovarian, hepatocellular, and oral cancer21–23,33.
The proliferation of hepatocellular carcinoma enhanced
by Hepatitis B virus X protein was attributed to down-
regulation of microRNA-15b which resulted in upregu-
lation of FUT2, leading to FUT2-induced Globo H
expression34. The involvement of FUT1 and FUT2 in
angiogenesis has also been elaborated22,35. In light of the
report of growth promotion by FUT1 in HER2-
overexpressing breast cancer26, our data in HER2 nega-
tive breast cancer indicated that FUT1 mediated alpha 1,
2-linked fucose plays a crucial role in breast cancer pro-
gression regardless of HER2 status.
Many glycan products of glycotransferases are known
to contribute to malignant tumor transformation in
cancer. Enhanced expression of glycotransferase such as
MGAT5 (mannoside acetyl glucosaminyl transferase 5)
that makes beta 1, 6-GlcNAc-containing N-glycans is
correlated with poor prognosis in breast and colorectal
carcinomas36,37. Suppression of EMT, cell motility,
tumor formation and metastasis were observed in
MGAT5-/- mice lacking beta 1, 6-GlcNAc-containing
glycans38. To date, FUT1 and its glycan products are
relatively better studied than FUT2 in relation to can-
cers. For example, Ley antigen expression has been
found at high levels in a variety of human epithelial
carcinomas. Suppression of FUT1 with reduced Ley
expression inhibited epidermoid carcinoma (A431) and
HER2-overexpressing breast cancer (NCI-N87) via
EGFR19,26, and decreased adhesion of dendritic cells
over endothelial cells via reduced Ley on ICAM-239. In
this study, the evidence linking Ley to various FUT1
related function was inferential, however, we showed
Fig. 5 FUT1 and FUT2 regulate the changes of EMT markers.
Western blots analysis showing expression of EMT markers in T47D or
MCF7 cells with vector control, FUT1 or FUT2 overexpression, or, FUT1
or FUT2 knockdown
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Fig. 6 (See legend on next page.)
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the contribution of Globo H-ceramide, a glycan product
of FUT1 and FUT2, to some of the phenotypes
attributable to FUT1/FUT2. Indeed, FUT2-induced
Globo H has been found to be increased by Hepatitis
B virus X protein to enhance hepatocellular carcinoma
proliferation34.
Smad3 null mice, a spontaneous colorectal model,
expressed abnormal pattern of alpha 1, 2-fucosylated
glycans with extremely high level of FUT2 mRNA, but
displayed no differences in the number and size of col-
orectal tumors regardless of the FUT2 genotype40. In
contrast, our study showed that FUT2 knockdown sig-
nificantly abrogated cellular proliferation, adhesion,
tumor formation in T47D, which implied a tissue-specific
role of FUT2 in different tissues/cells. In addition to their
functional redundancy, FUT1 and FUT2 may mediate
alpha 1, 2-fucosylation of different glycoproteins as
implied by Globo H-mediated reversal of FUT1 knock-
down reduced motility but not FUT2 knockdown
decreased adhesion. Consistent with this, previous studies
showed that FGA1 is lost from pancreas in FUT1-null
mice, whereas, both FGA1 and FGM1 are completely
absent in antrum, cecum, and colon in FUT2-null mice9.
FUT1 and FUT2 null mice display reduced expression
of FGM1 and FGA1, but no gross phenotypic
abnormalities8,41. FUT1 and FUT2 are responsible for
alpha 1, 2-fucosyltransferase, since a third alpha 1, 2-
fucosyltransferase gene called Sec1 is a pseudogene which
is inactivated by insertion of a nucleotide resulting in a
frameshift in the coding sequence42. Inhibition of cancer
cell progression, angiogenesis and metastasis by FUT1 or
FUT2 knockdown reduced expression of alpha 1, 2-
fucosyl glycans has been found in many cancers including
breast cancer. Besides, breast stromal cells express low
level of FUT1 and absent FUT2. Our and other studies
both demonstrate that FUT1 and FUT2 play crucial roles
in more than one subtype of breast cancer, at least
including HER2-overexpressing and HER2 negative26.




The human embryonic kidney cell line HEK293T and
Breast cancer cell lines T47D, MCF7, and MDA-MB-231
were obtained from American Type Culture Collection.
HEK293T, T47D and MDA-MB-231 were cultured in
Dulbecco’s Modified Eagle Medium (DMEM) with 10%
fetal bovine serum (FBS). MCF7 were cultured in Mini-
mum Essential Media (MEM) with 10% FBS.
Lentivirus Production and Transduction
The lentiviral constructs pLKO.1-puro harboring FUT1-
specific shRNA (TRCN0000036078 and TRCN0000036074),
FUT2-specific shRNA (TRCN0000036102, TRCN0000
431129, and TRCN0000418672), or shLuc (TRCN
0000231715) were obtained from the National RNAi Core
Facility (Institute of Molecular Biology/Genomic Research
Center, Academia Sinica, Taiwan). The VSV-G-pseudotyped
lentiviruses were produced by co-transfecting lentiviral-based
expression vector pLKO.1-puro harboring a specific shRNA
encoding sequence, packaging plasmid pCMV-R8.91, and
pMD.G into HEK293T cells. Infectious lentiviruses were
harvested at 72 h after transfection and were concentrated by
ultracentrifugation (25,000 rpm, 90min, 4 °C). T47D and
MCF7 cells were plated at 5 × 105 cells per well in six-well
plates and transduced with lentivirus in the presence of 8 μg/
ml polybrene (Sigma). The transduced T47D andMCF7 cells
were replaced with selective medium containing 0.5μg/ml
and 0.25 μg/ml puromycin (Sigma), respectively, at 72 h post-
transduction. The stable cells were still selected more than 5
day until the 90% death of control cells which were not
transduced with lentivirus.
Plasmid DNAs and Transfection
MCF7 and T47D genomic DNA were used as templates
for FUT1 and FUT2 in a PCR, respectively. Flag-tagged
FUT1 was amplified by a primer pair of Flag-FUT1-FW
(AAGAATTCACCATGGACTACAAAGACGATGACG
ACAAGATGTGGCTCCGG AGCC) and FUT1-REV (AA
GAATTCTCAAGGCTTAGCCAATGTCCAGAGTGGA
GAC). Flag-tagged FUT2 was amplified by a primer pair
of Flag-FUT2-FW (AAGAATTCACCATGGACTACA
AAGACGATGACGACAAGATGCTGGTCGTTCAGAT
GCCTTTC) and FUT2-REV (AAGAATTCTTAGTGCT
TGAGTAAGGGGGACAGG). The amplified Flag-FUT1
and Flag-FUT2 cDNA were inserted into EcoR I site of
pcDNA3.1 (Invitrogen). All transfection was performed
using electroporation. The condition of MCF7 was 900
voltage (V), 30 m-second (ms), 2 pulse (P); T47D was
(see figure on previous page)
Fig. 6 FUT1-modified glycans positively regulate cell migration through Globo H. a, Immunohistochemistry staining of Globo H expression in
excised T47D or MCF7 tumor xenografts expressing shLuc, shFUT1, or shFUT2 and flow cytometry analysis of Globo H in T47D, MCF7, and MDA-MB-
231 cells with indicated conditions. Scale bars, 50 μm. b, Flow analysis of Globo H expression in T47D or MCF7 cells expressing shLuc, shFUT1, or
shFUT2 with or without Globo H-ceramide. c, Cell adhesion ability of T47D cells expressing shFUT2 or shLuc to polystyrene in the presence or
absence of Globo H-ceramide were measured by RT-CES system up to 2 h. d, Cell migration toward serum of MCF7 cells expressing shLuc or shFUT1
in the presence or absence of Globo H-ceramide was determined by a RT-CIM system
Lai et al. Cell Death Discovery            (2019) 5:74 Page 9 of 12
Official journal of the Cell Death Differentiation Association
1400 V, 30ms, 1 P; MDA-MB-231 was 1400 V, 10ms, 3 P.
The ratio of cells to recombinant DNA is 1 × 106 cells to
10 μg of DNA. 3 × 106 cells were plated in 100mm Petri-
dish. The cells were harvested for subsequent analyses at
48 h post-transduction.
Quantitative real-time-PCR
Total RNA was extracted and reverse-transcripted to
cDNA with oligo(dT) primer. RT-PCR for simultaneous
detection and quantification of the cDNA samples was
performed on an ABI Prism 7300 Sequence Detection
System and analyzed with the ABI Prism 7300 SDS soft-
ware (Applied Biosystems). SYBR Green I detection
(Applied Biosystems) was used to detect FUT1 and FUT2
gene expression. The primers were as follows: FUT1:
CCGGTTTGGTAATCAGATGG and CTCAAGTCCG
CGTACTCCTC as well as FUT2: ATCATGACCAT
TGGGACGTT and GTGCTTGAGTAAGGGGGACA
from previous study43. The cDNA sample were used for
qPCR reaction as 50 °C for 2 min, 95 °C for 10min, fol-
lowed by 40 cycles of 95 °C for 10 s and 60 °C for 1 min.
The end-point used in the real-time quantification was
calculated by the ABI Prism 7300 SDS software, and the
threshold cycle number (Ct value) for each analyzed
sample was calculated. GAPDH was used as the internal
control in SYBR Green system.
Flow Cytometry
Aliquots of cells (1 × 105) were stained with anti-Globo
H-Alexa488 (Vk9)10, or anti-CD24-PE and anti-CD44-
APC antibodies at 4 °C for 1 h. All analyses were done
with a FACSCanto flow cytometer using the CellQuest
program (BD Biosciences).
Wound healing motility assay
Cells were plated on 6-well plates until confluent, and
then were starved for overnight. The cell monolayer was
scratched with a linear scratch by a sterile 200 μl pipette
tip. After scratching, cell monolayer was washed once
with PBS then cultivated with 5% FBS containing med-
ium. The wounded areas were photographed at 0 and 48 h
after scratching. The wounded areas at 0 h and remain
area at 48 h were calculated by image J software.
Cell adhesion assay
Cell adhesion was assessed using RT-CES apparatus
(Real Time Cell Electronic Sensing, ACEABIO). ACEA’s
96 microtiter plates were coated with the appropriate
dilution in PBS of fibronectin (25 μg/ml, Sigma), type IV
collagen (2 μg/ml, BD biosciences), or laminin (5 μg/ml,
Sigma) at 37 °C for 1 h and then were blocked with 1%
BSA for 1 h at 37 °C. Cells were seeded at 2.5 × 104 per
100 μl of culture medium in ACEA’s 96 microtiter plates.
Cell adhesion was continuously monitored every 10 min
using the RT-CES for a period of 1 h. For the exogenous
addition of Globo H-ceramide, cells were incubated with
50 μg/ml Globo H-ceramide in serum-free medium for
overnight.
Cell migration
Cell migration was measured using a RT-CIM apparatus
(ACEABIO). Cells were starved overnight in serum-free
medium, and then seeded at 5 × 104 per 100 μl with
serum-free medium in the upper chamber with 8 μM pore
size. The lower chamber was contained 10% serum
medium. Cell migration was continuously monitored
every 2 h by ACEA’s 16 microtiter plates for a period of 0
to 18 h.
Cell invasion
The 50 μl of matrigel was prepared in chill serum-free
medium in a concentration of 1 mg/ml and placed onto
the upper chamber of transwell (24-well, Corning). After
incubation at 37 °C for 1 h, 10% FBS (v/v) was supple-
mented in medium and placed in the lower chamber as a
chemoattractant. Then, 1 × 105 cells in serum-free med-
ium were added to the upper chamber and incubated at
37 °C for 24 h. For quantification, cells were fixed with 4%
formalin, and subsequently stained with 0.2% crystal
violet. After the upper side of the membrane was gently
wiped, at least five fields of invading side were imaged and
the attached cells were counted.
Cell proliferation assay
Cells were seeded at 2.5 × 103 cells per well on 96-well
plates (Corning). At 24, 48, 72, and 96 h after cells seeded,
alamar blue (BioRad) was added to a final concentration
of 1/10 dilution and cells were harvested at 37 °C, 5% CO2
for 3 h. The absorbance was measured at 544/590 nm and
determined by SpectraMax M2 Reader. Assays were
performed in triplicate.
Mammosphere formation assay
Single cell suspensions of cell lines were suspended at a
density of 1,000 cells/ 150 μl in DMEM/F12 containing
0.4% BSA, 10 ng/ml EGF, 20 ng/ml bFGF, 1 μM hydro-
cortisone, and 1x B27 supplement and then were seeded
on ultra low attachment plates (Corning). Cultures were
fed weekly over than two weeks.
Tumorigenicity assays
Six-week-old NOD/SCID mice were purchased from
National Laboratory Animal Center, Taiwan. T47D (5 ×
106) or MCF7 cells (1 × 107) expressing shLuc, shFUT1, or
shFUT2 in 0.1 ml of 50% Matrigel (BD Biosciences) plus
50% supplemented RPMI-1640 were injected sub-
cutaneously into mammary fat pad of 8-week-old, female
mice. The tumor volume was regularly monitored by
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measuring the length (l) and width (w) and calculating the
volume (V= π / 6 × l ×w × [l+w] / 2). At the end of the
experiment, the animals were sacrificed and the tumors
were excised and weighed.
Bioluminescence imaging
The MDA-MB-231 cells were transduced with the
lentivirus containing the plasmid pLKO.CMV.luc.GFP.
GFP+ cells at 95% purity sorted by FACS were then
transfected with empty vector pcDNA3.1, Flag-FUT1 or
Flag-FUT2 containing vectors followed by selection with
1 mg/ml G418 (Promega). The cells (3 × 106) were injec-
ted intravenously through the tail vein of the NOD/SCID
mice (n= 3 in each group, power= 0.80, α= 0.05) and
three individual experiments were carried out. The sub-
strate luciferin (Nanolight) was injected into the intra-
peritoneal cavity of the mice at 75 mg/kg (15 mg/ml
luciferin), ~5 minutes before imaging. Mice were anes-
thetized with 2.5% isoflurane/oxygen and placed on the
imaging stage. Ventral and dorsal images were collected
for 1 minute using the IVIS (Xenogen). Photons emitted
from the lung region were quantified using Living Image
software v2.6 (Xenogen). After sacrifice, lungs were
excised, fixed in 10% formalin (Sigma, St. Louis, MO,
USA) and prepared for standard histopathology
evaluation.
Western Blotting
Cells were incubated in buffer containing 50mM Tris
pH 7.2, 300mM NaCl, 1% Triton X-100, a panel of pro-
tease inhibitor mixture, and 2mM sodium orthovanadate
for 20 min. Whole cell lysates were subjected to NuPAGE
(10% Bis-Tris gels, Invitrogen) and Western blotting with
anti-E-cadherin antibody (BD Biosciences), anti-twist
antibody (Santa Cruz), anti-fibronectin antibody (Milli-
pore), anti-vimentin antibody (Abcam, 5G3F10), and anti-
tubulin (Sigma). The immunoblots were developed with
the ECF system (GE Healthcare).
Immunohistochemistry
T47D and MCF7 tumor xenografts from NOD/SCID
mice were fixed in 10% phosphate-buffered formalin and
embedded in paraffin. Paraffin sections were cut at a
thickness of 2 μm, mounted on SuperFrostTM Plus
microscopy slides (Menzel-Gläser), and dried at 70 °C for
2 h. The sections were dewaxed in xylene and rehydrated
according to the standard histopathological procedures.
The slides were first placed in the solution of Tris-EDTA
pH 9.0 and autoclaved for 7.5 min for antigen retrieval.
The slides were then blocked with 3% hydrogen peroxide
for 15min and incubated with biotin conjugated UEA-1
lectin (Vector Laboratories) for 1 h at room temperature
followed by fluorescein-conjugated streptavidin (Jackson
ImmunoResearch) for 1 h at room temperature. Finally,
the slides were stained with Hoechst 33258 for 15min and
mounted with Vectashield (Vector Laboratories). For
Globo H staining, the slides were stained using Bench-
mark XT machine (Ventana). The slides were added with
anti-Globo H antibody (Vk9) in power block HK085-5K
solution (Ventana) at 37 °C for 1 h followed by biotin
conjugated anti-IgG and streptavidin-HRP for 20 min and
applied with iVIEW DAB Detection kit (Ventana). Leica
autostainer XL (CV5030) machine was then used for
counter staining with Mayer’s hematoxylin and mounting.
The images were collected with Leica automatic upright
microscope (DM 6000B).
Statistical Analysis
All experiments were repeated at least three times. The
data were analyzed using the two-tailed Student’s t test or
one-way ANOVA, depending on number of groups
compared. When one-way ANOVA was taken, we per-
formed Tukey’s range test as post hoc test to analyze the
variances. For both methods, a P value of 0.05 or less was
considered significant. The statistical analyses were per-
formed with Prism 5.0 (GraphPad Software, La Jolla, CA,
USA)
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